Revisiting Beta-Blocker Therapy in Heart Failure with Preserved Ejection Fraction
Rasha Kaddoura, Ashfaq Patel
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a heterogenous disorder and tends to be predominant in elderly, female, and obese patients. HFpEF has been classified using various cut-offs of left ventricular ejection fraction in the published studies with a current cut-off of ≥50%. The evidence of beta-blocker therapy in HFpEF patients showed conflicting findings with variably reported efficacy. This review aims to examine the published studies on the use of beta blockers for the treatment of patients with HFpEF.
Topics & Concepts
MedicineHeart failure with preserved ejection fractionEjection fractionCardiologyHeart failureInternal medicineBETA (programming language)Beta blockerComputer scienceProgramming languageHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiac electrophysiology and arrhythmias